Skip to main content
2025 Vascular Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed Event
Ticketed Event

Trisha Roy, MD, PhD

Houston Methodist Hospital
Houston, Texas

Dr. Trisha Roy is an internationally renowned vascular surgeon-scientist transforming peripheral vascular disease treatment through groundbreaking imaging and device innovation. As Associate Professor at Weill Cornell Medical College and Houston Methodist Academic Institute, she directs the Peripheral Vascular Translational Imaging Laboratory, developing cutting-edge MRI techniques that revolutionize treatment planning and outcomes.

Dr. Roy also founded the Houston Methodist Peripheral Vascular Device Core—the only facility worldwide utilizing proprietary MRI techniques to analyze complex disease in actual patient limbs—addressing urgent device safety concerns while partnering with industry to develop next-generation technologies. Her innovations include the patented CathPilot steering catheter and a first-of-its-kind human cadaveric model providing unprecedented insights into device-tissue interactions.

Her exceptional research has secured NIH R01 funding and the American Heart Association Transformational Project Award. Global recognition includes the prestigious international Vanier Scholarship, awarded to elite doctoral candidates demonstrating world-class scholarly achievement, and first-place awards from the European Society for Vascular Surgery and Society for MR Angiography.

Dr. Roy is Board-certified in Vascular Surgery with fellowship in the Royal College of Surgeons of Canada and American Board of Surgery. She also serves on the editorial board of prestigious journals including Journal of Vascular Surgery-Vascular Science. Her unique expertise combining materials engineering, advanced MRI techniques, and clinical practice in limb preservation exemplifies translational medicine at its finest, improving outcomes for patients with complex vascular disease worldwide.

Presentation(s):